SPART Chromosome 13
Spartin
Upload your DNA to see your personal genotypes for variants in SPART.
What This Gene Does
This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome). [provided by RefSeq, Nov 2008]
Associated Conditions (14)
Troyer syndrome
Hereditary spastic paraplegia
SPART-related disorder
Inborn genetic diseases
Gastric cancer
Thyroid cancer
nonmedullary
1
Hepatocellular carcinoma
Lung cancer
Cervical cancer
Ovarian serous cystadenocarcinoma
Neurodevelopmental delay
6 conditions
Key Variants
RS1399213398
Conflicting classifications of pathogenicity
Troyer syndrome, Troyer syndrome
Health Risk
RS140222511
Conflicting classifications of pathogenicity
Troyer syndrome, Troyer syndrome
Health Risk
RS142482393
Conflicting classifications of pathogenicity
Troyer syndrome, Troyer syndrome
Health Risk
RS146398746
Conflicting classifications of pathogenicity
Troyer syndrome, Hereditary spastic paraplegia, SPART-related disorder
Health Risk
RS148399669
Conflicting classifications of pathogenicity
Troyer syndrome, Hereditary spastic paraplegia, Troyer syndrome
Health Risk
RS148672324
Conflicting classifications of pathogenicity
Troyer syndrome, Inborn genetic diseases, Troyer syndrome
Health Risk
RS148833652
Conflicting classifications of pathogenicity
Troyer syndrome, Hereditary spastic paraplegia, Inborn genetic diseases
Health Risk
RS149393698
Conflicting classifications of pathogenicity
Troyer syndrome, Hereditary spastic paraplegia, SPART-related disorder
Health Risk
RS149730980
Conflicting classifications of pathogenicity
Troyer syndrome, Troyer syndrome
Health Risk
RS192704075
Conflicting classifications of pathogenicity
Troyer syndrome, Troyer syndrome
Health Risk
RS368305530
Conflicting classifications of pathogenicity
Hereditary spastic paraplegia, Inborn genetic diseases, Ovarian serous cystadenocarcinoma
Health Risk
RS370385005
Conflicting classifications of pathogenicity
Troyer syndrome, Troyer syndrome
Health Risk
All Variants (36)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS1399213398 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Troyer syndrome |
| RS140222511 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Troyer syndrome |
| RS142482393 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Troyer syndrome |
| RS146398746 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Hereditary spastic paraplegia, SPART-related disorder |
| RS148399669 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Hereditary spastic paraplegia, Troyer syndrome |
| RS148672324 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Inborn genetic diseases, Troyer syndrome |
| RS148833652 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Hereditary spastic paraplegia, Inborn genetic diseases |
| RS149393698 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Hereditary spastic paraplegia, SPART-related disorder |
| RS149730980 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Troyer syndrome |
| RS192704075 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Troyer syndrome |
| RS368305530 | Health Risk | Conflicting classifications of pathogenicity | Hereditary spastic paraplegia, Inborn genetic diseases, Ovarian serous cystadenocarcinoma |
| RS370385005 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Troyer syndrome |
| RS567106287 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Troyer syndrome |
| RS571222120 | Health Risk | Conflicting classifications of pathogenicity | Troyer syndrome, Troyer syndrome |
| RS750885553 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS769573100 | Health Risk | Conflicting classifications of pathogenicity | Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS1555263116 | Health Risk | Likely pathogenic | — |
| RS2137548453 | Health Risk | Likely pathogenic | Neurodevelopmental delay, Neurodevelopmental delay |
| RS2137548824 | Health Risk | Likely pathogenic | Troyer syndrome, Troyer syndrome |
| RS2500723740 | Health Risk | Likely pathogenic | — |
| RS771101723 | Health Risk | Likely pathogenic | Troyer syndrome, Troyer syndrome |
| RS779688963 | Health Risk | Likely pathogenic | — |
| RS1060499524 | Health Risk | Pathogenic | Troyer syndrome, SPART-related disorder, Troyer syndrome |
| RS1233117382 | Health Risk | Pathogenic | — |
| RS1480709252 | Health Risk | Pathogenic | — |
| RS1883463670 | Health Risk | Pathogenic | — |
| RS200373703 | Health Risk | Pathogenic | Neurodevelopmental delay, Troyer syndrome, Neurodevelopmental delay |
| RS2137335988 | Health Risk | Pathogenic | Troyer syndrome, Troyer syndrome |
| RS2137515973 | Health Risk | Pathogenic | Troyer syndrome, Troyer syndrome |
| RS730882198 | Health Risk | Pathogenic | 6 conditions, Troyer syndrome, 6 conditions |
| RS745516122 | Health Risk | Pathogenic | — |
| RS748835312 | Health Risk | Pathogenic | — |
| RS775736341 | Health Risk | Pathogenic | Troyer syndrome, Inborn genetic diseases, Neurodevelopmental delay |
| RS777288668 | Health Risk | Pathogenic | Troyer syndrome, Troyer syndrome |
| RS748865622 | Health Risk | Pathogenic/Likely pathogenic | SPART-related disorder, SPART-related disorder |
| RS770560051 | Health Risk | Pathogenic/Likely pathogenic | Troyer syndrome, Troyer syndrome |